Is GLMD or GOSS more undervalued in 2026?

CirclFi compares Galmed Pharmaceuticals Ltd. (GLMD) and Gossamer Bio, Inc. (GOSS) using 13 institutional-grade valuation models. GLMD has a Quality of Company score of 1.7/10 while GOSS scores 5.3/10.

Which is a better buy — GLMD or GOSS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GLMD and GOSS valuations compare?

GLMD at $0.68 and GOSS at $0.21 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GLMD vs GOSS Valuation Comparison 2026 — Intrinsic Value Analysis

GLMD

Biotechnology

Galmed Pharmaceuticals Ltd.

Quality

1.7

out of 10

Value Trap

SAFE

Price

$0.68

Last close

Models

9/13

Active

GOSS

Biotechnology

Gossamer Bio, Inc.

Quality

5.3

out of 10

Value Trap

SAFE

Price

$0.21

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	GLMD Fair Value	GLMD Upside	GOSS Fair Value	GOSS Upside
Bayesian DCF	Intrinsic	$0.18	-73.5%	$0.14	-31.7%
EROIC Spread	Intrinsic	$3.09	+392.8%	—	—
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.20	+93.4%	$0.08	-62.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GLMD vs GOSS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GLMD vs GOSS — Which Stock Is More Undervalued?

GOSS scores higher with a 5.3/10 quality rating vs GLMD's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Galmed Pharmaceuticals Ltd. (GLMD) and Gossamer Bio, Inc. (GOSS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GLMD currently trades at $0.68 with a QOC of 1.7/10, while GOSS trades at $0.21 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).